Inpatient oncology length of stay and hospital costs: Implications for rising inpatient expenditures

Journal of Applied Research

Volumn 6, Issue 2, 2006, Pages 126-131

  Suda, Katie J ^a   Motl, Susannah E ^b   Kuth, John C ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cost; Inpatient; Oncology; Outcomes

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CONTROLLED STUDY; DEMOGRAPHY; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; TERTIARY HEALTH CARE; UNITED STATES;

EID: 33746402885     PISSN: 1537064X     EISSN: 1537064X     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Hoffman JM, Shah ND, Vermeulen LC, et al. Projecting future drug expenditures - 2006. AJHP. 2006;63:123-138.
3. van Agthoven M, van Ineveld BM, de Boer MF, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer. 2001:37:2204-2211.
4. Dedes KJ, Szucs TD, Bodis S, et al. Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics. 2004;22:435-444.
5. Wolstenholme JL, Whynes DK. The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer. 1998;80:215-218.
6. Motl SE, Suda KJ, Kuth JC, Gladney TJ. Racial comparison of outcomes and cost of inpatient neutropenic patients: a multicenter evaluation. J Oncol Prac. 2006;2:53-56.